MANNKIND CORP (MNKD): Unregistered Sales of Equity Securities
MANNKIND CORP (MNKD) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. EX-4.2 3 d63182dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “ Agreement ”), dated as of July 23, 2026, is entered into by and among MannKind Corporation, a Delaware corporation (the “ Company ”), and the several invest
How this was made
The 30-second read
Why it matters
This disclosure frames the company’s obligation to file a resale registration statement within 30 days of the closing date, which can affect how investors model future dilution and potential warrant exercise behavior.
Market read
A $50 million unregistered equity sale with registration rights is disclosed, with a stated 30-day filing deadline for a resale registration statement.
What to watch
Traders will need the related purchase agreement details (share count, warrant terms, and any resale limits) to gauge actual dilution and near-term selling pressure.
Background
The 8-K Item 3.02 is accompanied by a registration rights agreement dated July 23, 2026, covering resale registration for shares and pre-funded warrants issued under a securities purchase agreement.
Ticker impact
MannKind filed an 8-K for Item 3.02, disclosing unregistered equity sales tied to a $50 million stock and pre-funded warrant purchase.
Likely limited immediate impact unless traders focus on dilution size versus liquidity; watch for follow-through on registration statement timing.
The text is a regulatory disclosure of unregistered sales and registration rights, including a stated $50 million purchase amount, but it does not provide pricing, share count, or immediate operational catalysts.
Market effects
Routine for biotech/specialty pharma capital structures; may modestly influence sentiment around small-cap financing risk.
None specific beyond US small-cap equity issuance mechanics.
None specific.
Counterpoint
Registration rights can reduce overhang risk if the company files promptly, so the market may treat this as administrative rather than dilutive.
Key entities
- issuerMannKind Corporation
Subject of the SEC 8-K, providing registration rights for shares and pre-funded warrants issued in an unregistered sale.
- counterpartiesInvestors (signatory group)
Holders purchasing $50.0 million of common stock and/or pre-funded warrants under the purchase agreement.
- regulatorSEC
Registration statement effectiveness and filing obligations referenced in the agreement.
